Determining the Potential Role of Tolerance as a Novel HIV Vaccine Strategy

Barry Peters of Kings College London will study the balance of tolerizing and stimulating immunity in HIV patients identified as "long-term non-progressors" in an effort to determine whether it is development of tolerance to HIV, and not immunity, which prevents the progression of the disease to AIDS.